Topical Treatment with 5% Imiquimod for Solitary Keratoacanthoma / 대한피부과학회지
Korean Journal of Dermatology
;
: 1321-1324, 2004.
Artigo
em Coreano
| WPRIM
| ID: wpr-109651
ABSTRACT
Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5% cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5% cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Recidiva
/
Carcinoma de Células Escamosas
/
Nariz
/
Seguimentos
/
Diagnóstico
/
Ceratoacantoma
Tipo de estudo:
Estudo diagnóstico
/
Estudo observacional
/
Estudo prognóstico
Limite:
Adulto
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS